XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents $ 263 $ 137
Accounts receivable, net of allowance for doubtful accounts of $10 and $13 as of September 30, 2018 and December 31, 2017, respectively 1,097 924
Inventories 95 95
Prepaid expenses and other current assets 148 150
Total current assets 1,603 1,306
Property, plant and equipment, net 1,194 1,145
Goodwill 6,447 6,335
Intangible assets, net 1,168 1,119
Investment in equity method investees 456 462
Other assets 118 136
Total assets 10,986 10,503
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,085 1,021
Current portion of long-term debt 304 36
Total current liabilities 1,389 1,057
Long-term debt 3,394 3,748
Other liabilities 761 663
Commitments and contingencies
Redeemable noncontrolling interest 77 80
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2018 and December 31, 2017; 217 and 216 shares issued as of September 30, 2018 and December 31, 2017, respectively 2 2
Additional paid-in capital 2,656 2,612
Retained earnings 7,546 7,138
Accumulated other comprehensive loss (58) (48)
Treasury stock, at cost; 81 shares as of both September 30, 2018 and December 31, 2017 (4,829) (4,783)
Total Quest Diagnostics stockholders' equity 5,317 4,921
Noncontrolling interests 48 34
Total stockholders' equity 5,365 4,955
Total liabilities and stockholders' equity $ 10,986 $ 10,503